We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+3.19%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$1.77B
AUM Growth
+$95.6M
Cap. Flow
+$79.9M
Cap. Flow %
4.52%
Top 10 Hldgs %
10.21%
Holding
1,825
New
561
Increased
356
Reduced
388
Closed
510

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$21.7M
2
HLF icon
Herbalife
HLF
+$20.4M
3
TXRH icon
Texas Roadhouse
TXRH
+$18M
4
BKNG icon
Booking.com
BKNG
+$17.7M
5
LOW icon
Lowe's Companies
LOW
+$15.5M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$14.3M
2
UPS icon
United Parcel Service
UPS
+$10.8M
3
LULU icon
lululemon athletica
LULU
+$9.52M
4
AMZN icon
Amazon
AMZN
+$8.2M
5
GILD icon
Gilead Sciences
GILD
+$7.98M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.14%
2 Technology 14.57%
3 Healthcare 11.17%
4 Industrials 9.82%
5 Financials 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCON
1301
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$17K ﹤0.01%
+129
New +$20.4K
HSTO
1302
DELISTED
Histogen Inc. Common Stock
HSTO
$16K ﹤0.01%
302
-321
-52% -$55.7K
KUST
1303
Kustom Entertainment Inc
KUST
$639K
0
MTNB icon
1304
Matinas BioPharma
MTNB
$1.88M
$14K ﹤0.01%
+316
New +$15.2K
MARK
1305
DELISTED
Remark Holdings, Inc.
MARK
$14K ﹤0.01%
1,620
-3,615
-69% -$42.5K
GPL
1306
DELISTED
Great Panther Mining Limited
GPL
$13K ﹤0.01%
+1,543
New +$12.5K
SPHS
1307
DELISTED
Sophiris Bio, Inc.
SPHS
$12K ﹤0.01%
+14,704
New +$12.9K
MVIS icon
1308
Microvision
MVIS
$86.6M
$8K ﹤0.01%
+10,209
New +$9.07K
SSI
1309
DELISTED
Stage Stores Inc
SSI
$8K ﹤0.01%
+10,683
New +$10.5K
FRED
1310
DELISTED
Fred's Inc
FRED
$8K ﹤0.01%
+15,955
New +$15.4K
ZN
1311
DELISTED
Zion Oil & Gas, Inc.
ZN
$7K ﹤0.01%
20,929
+700
+3% +$379
TRNX
1312
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$2K ﹤0.01%
+2,266
New +$5.72K
ACA icon
1313
Arcosa
ACA
$7.13B
-38,777
Closed -$1.19M
ACHC icon
1314
Acadia Healthcare
ACHC
$3.01B
-9,714
Closed -$285K
ACIW icon
1315
ACI Worldwide
ACIW
$6.1B
-9,711
Closed -$319K
ACRE
1316
Ares Commercial Real Estate
ACRE
$256M
-15,377
Closed -$234K
ADAP
1317
DELISTED
Adaptimmune Therapeutics
ADAP
-24,111
Closed -$104K
ADVM
1318
DELISTED
Adverum Biotechnologies
ADVM
-1,737
Closed -$91K
AEM icon
1319
Agnico Eagle Mines
AEM
$71.9B
-46,000
Closed -$2M
AGM icon
1320
Federal Agricultural Mortgage
AGM
$2.31B
-3,476
Closed -$252K
AGO icon
1321
Assured Guaranty
AGO
$3.79B
-4,800
Closed -$213K
AKAM icon
1322
Akamai
AKAM
$16.3B
-15,144
Closed -$1.09M
ALG icon
1323
Alamo Group
ALG
$2B
-3,965
Closed -$396K
ALLK
1324
DELISTED
Allakos
ALLK
-6,986
Closed -$283K
ALNT icon
1325
Allient
ALNT
$1.42B
-8,988
Closed -$206K

Similar funds

A.R.T. Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, A.R.T. Advisors held 1,825 positions worth $1.77B, up 5.7% from $1.67B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

A.R.T. Advisors deployed $79.9M of net new capital in Q2 2019, opening 561 new positions and adding to 356 existing holdings. Its largest new stake was Nike: 257,500 shares worth $21.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was lululemon athletica, an estimated $9.52M trimmed.

  • A.R.T. Advisors's largest Q2 2019 buy was Nike: 257,500 shares worth $21.6M.
  • A.R.T. Advisors added most to Herbalife in Q2 2019, an estimated $20.4M increase.
  • A.R.T. Advisors's biggest Q2 2019 reduction was lululemon athletica, cutting an estimated $9.52M.
  • A.R.T. Advisors fully exited Starbucks in Q2 2019, selling an estimated $14.3M.
  • A.R.T. Advisors's ten largest holdings make up 10% of its $1.77B portfolio in Q2 2019.
  • A.R.T. Advisors opened 561 new positions and closed 510 in Q2 2019.
  • A.R.T. Advisors's portfolio value rose 5.7% quarter-over-quarter to $1.77B.

Based on A.R.T. Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.